These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38302369)

  • 1. Corrigendum to "Lapatinib ditosylate rescues motor deficits in rotenone-intoxicated rats: Potential repurposing of anti-cancer drug as a disease-modifying agent in Parkinson's disease" [Eur. J. Pharmacol. 954 (2023) 175875].
    Mansour HM; Mohamed AF; Khattab MM; El-Khatib AS
    Eur J Pharmacol; 2024 Mar; 966():176371. PubMed ID: 38302369
    [No Abstract]   [Full Text] [Related]  

  • 2. Lapatinib ditosylate rescues motor deficits in rotenone-intoxicated rats: Potential repurposing of anti-cancer drug as a disease-modifying agent in Parkinson's disease.
    Mansour HM; F Mohamed A; Khattab MM; El-Khatib AS
    Eur J Pharmacol; 2023 Sep; 954():175875. PubMed ID: 37385578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratum to "Neuroprotective repositioning and anti-tau effect of carvedilol on rotenone induced neurotoxicity in rats: Insights from an insilico & in vivo anti-Parkinson's disease study" [Eur. J. Pharmacol. 932 (2022) 175204].
    Kamal RE; Menze E; Albohy A; Ahmed HI; Azab SS
    Eur J Pharmacol; 2023 Apr; 945():175534. PubMed ID: 36870913
    [No Abstract]   [Full Text] [Related]  

  • 4. Lapatinib ditosylate rescues memory impairment in D-galactose/ovariectomized rats: Potential repositioning of an anti-cancer drug for the treatment of Alzheimer's disease.
    Mansour HM; Fawzy HM; El-Khatib AS; Khattab MM
    Exp Neurol; 2021 Jul; 341():113697. PubMed ID: 33727095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory, anti-apoptotic, and neuroprotective potentials of anethole in Parkinson's disease-like motor and non-motor symptoms induced by rotenone in rats.
    Moradi Vastegani S; Khoshnam SE; Mansouri E; Ghafouri S; Bakhtiari N; Farbood Y; Sarkaki A
    Metab Brain Dis; 2023 Aug; 38(6):2159-2174. PubMed ID: 37204660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson's disease.
    Balakrishnan R; Vijayraja D; Mohankumar T; Manimaran D; Ganesan P; Choi DK; Elangovan N
    J Chem Neuroanat; 2021 Mar; 112():101890. PubMed ID: 33220427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
    Parkhe A; Parekh P; Nalla LV; Sharma N; Sharma M; Gadepalli A; Kate A; Khairnar A
    Neurosci Lett; 2020 Jan; 716():134652. PubMed ID: 31778768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omarigliptin attenuates rotenone-induced Parkinson's disease in rats: Possible role of oxidative stress, endoplasmic reticulum stress and immune modulation.
    Michel HE; Tadros MM; Hendy MS; Mowaka S; Ayoub BM
    Food Chem Toxicol; 2022 Jun; 164():113015. PubMed ID: 35439590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of 2-(2-thienyl) benzothiazoline on gross motor skill deficits in rotenone induced rat model of Parkinson's disease.
    Sadiq R; Musaddiq S; Iqbal F; Kanwal S; Perveen S
    Pak J Pharm Sci; 2022 Mar; 35(2):435-440. PubMed ID: 35642397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trehalose ameliorates prodromal non-motor deficits and aberrant protein accumulation in a rotenone-induced mouse model of Parkinson's disease.
    Moon SH; Kwon Y; Huh YE; Choi HJ
    Arch Pharm Res; 2022 Jun; 45(6):417-432. PubMed ID: 35618982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between subclinical doses of the Parkinson's disease associated gene, α-synuclein, and the pesticide, rotenone, precipitates motor dysfunction and nigrostriatal neurodegeneration in rats.
    Naughton C; O'Toole D; Kirik D; Dowd E
    Behav Brain Res; 2017 Jan; 316():160-168. PubMed ID: 27585560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement in the therapeutic potential of lapatinib ditosylate against breast cancer by the use of β-cyclodextrin based ternary nanosponge system.
    Tanaji Mane P; Sopanrao Wakure B; Shridhar Wakte P
    Int J Pharm; 2023 Jul; 642():123210. PubMed ID: 37433350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tryptophan in the diet ameliorates motor deficits in a rotenone-induced rat Parkinson's disease model via activating the aromatic hydrocarbon receptor pathway.
    Wang Y; Chen S; Tan J; Gao Y; Yan H; Liu Y; Yi S; Xiao Z; Wu H
    Brain Behav; 2021 Aug; 11(8):e2226. PubMed ID: 34105899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The behavioural and neuropathological impact of intranigral AAV-α-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats.
    Mulcahy P; O'Doherty A; Paucard A; O'Brien T; Kirik D; Dowd E
    Behav Brain Res; 2013 Apr; 243():6-15. PubMed ID: 23295396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recuperative effect of estrogen on rotenone-induced experimental model of Parkinson's disease in rats.
    Makav M; Eroğlu HA
    Environ Sci Pollut Res Int; 2021 May; 28(17):21266-21275. PubMed ID: 33410082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of cyclosporine A on neurodegeneration and motor impairment in rotenone-induced experimental models of Parkinson's disease.
    Singh S; Ganguly U; Pal S; Chandan G; Thakur R; Saini RV; Chakrabarti SS; Agrawal BK; Chakrabarti S
    Eur J Pharmacol; 2022 Aug; 929():175129. PubMed ID: 35777442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JM-20, a novel hybrid molecule, protects against rotenone-induced neurotoxicity in experimental model of Parkinson's disease.
    Fonseca-Fonseca LA; Wong-Guerra M; Ramírez-Sánchez J; Montano-Peguero Y; Padrón Yaquis AS; Rodríguez AM; da Silva VDA; Costa SL; Pardo-Andreu GL; Núñez-Figueredo Y
    Neurosci Lett; 2019 Jan; 690():29-35. PubMed ID: 30304707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoterpenoid Epoxidiol Ameliorates the Pathological Phenotypes of the Rotenone-Induced Parkinson's Disease Model by Alleviating Mitochondrial Dysfunction.
    Aleksandrova Y; Chaprov K; Podturkina A; Ardashov O; Yandulova E; Volcho K; Salakhutdinov N; Neganova M
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of anethole against rotenone induced non-motor deficits and oxidative stress in rat model of Parkinson's disease.
    Vastegani SM; Khoshnam SE; Mansouri E; Hajipour S; Ghafouri S; Bakhtiari N; Sarkaki A; Farbood Y
    Behav Brain Res; 2023 Feb; 437():114100. PubMed ID: 36075399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient exposure to rotenone causes degeneration and progressive parkinsonian motor deficits, neuroinflammation, and synucleinopathy.
    Van Laar AD; Webb KR; Keeney MT; Van Laar VS; Zharikov A; Burton EA; Hastings TG; Glajch KE; Hirst WD; Greenamyre JT; Rocha EM
    NPJ Parkinsons Dis; 2023 Aug; 9(1):121. PubMed ID: 37567894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.